It has been a very busy time at the National Lipid Association (NLA) and within our NLA chapters. We continue to move forward with integrating our work with other like-minded organizations. We were pleased to welcome a presentation on genetic counseling to help our members understand what can be expected, and potential benefits from a genetic consult at the Fall Clinical Lipid Update in late August in Amelia Island, Fla.

Article By:

Joyce L. Ross, MSN, CRNP, FPCNA, FNLA

President, National Lipid Association
Consultative Education Specialist
Cardiovascular Risk Intervention
University of Pennsylvania Health System – Retired
Philadelphia, PA
Diplomate, Accreditation Council for Clinical Lipidology

0
No votes yet
Last Updated: Wednesday, 07-Dec-2016 21:30:00 EST

December 7, 2017 — The National Lipid Association (NLA) was recently awarded accredited provider status for Joint Accreditation in Inter-professional Continuing Education. Joint Accreditation offers organizations such as the NLA the opportunity to be simultaneously accredited to provide medical, pharmacy, and nursing continuing education through a unified set of accreditation standards. The NLA now joins a growing list of organizations offering joint accreditation including medical societies, health systems, universities, medical education companies, and others.

Last Updated: Tuesday, 22-Nov-2016 20:15:00 EST

Led by the efforts of Carl Orringer, MD, FNLA, the National Lipid Association (NLA) has released the updated NLA Self-Assessment Program (NLA-SAP). The new program  now available for purchase  improves on the already existing NLA product that will continue to enhance your clinical knowledge of the core curriculum in clinical lipidology as well as challenge your problem-solving skills in the diagnosis and management of patients with dyslipidemia.

Last Updated: Tuesday, 22-Nov-2016 17:15:00 EST

As part of the recent launch of the RADAR Campaign (RADAR: RAre Disease AwaReness), the Foundation of the National Lipid Association has released a digital cookbook featuring recipes geared toward the patient with Familial Chylomicronemia Syndrome (FCS). The recipes included in the cookbook are low- to no-fat options offering a variety of healthy alternatives that are tasty and flavorsome! In addition to the cookbook, tearsheets and other patient resources were created to help improve the identification and management of rare lipid disorders.

Last Updated: Tuesday, 01-Nov-2016 18:30:00 EDT

 

The National Lipid Association is proud to announce the first-ever NLA Junior Faculty Research Award. The purpose of the award is to encourage scholarly advancement of Junior Faculty in the pursuit of a career related to hyperlipidemia and other lipid disorders in humans.

The award will be funded for three years, with two award cycles: Basic Science Award and Clinical Science Award.

Last Updated: Wednesday, 19-Oct-2016 13:30:00 EDT

Order Dyslipidemia GUIDELINES Pocket Card Part 1 and Part 2. Pocket cards include: Key Points, Lifestyle, General Management, Risk Assessment, Treatment Recommendations, Hypercholesterolemia, Algorithms, Charts, and Tables on Risk Calculators, Criteria for Classification for ASCVD, and more. Choose between print or digital download.

Last Updated: Monday, 03-Oct-2016 14:00:00 EDT

The new ICD-10 Codes released by the Center for Medicare & Medicaid Services (CMS) are now in effect. The codes became effective October 1, 2016.  The two new specific codes for FH are:

  • E78.01: Familial hypercholesterolemia
  • Z83.42: Family history of familial hypercholesterolemia

The National Lipid Association (NLA) in collaboration with the FH Foundation submitted a proposal to the ICD-10 Coordination and Maintenance Committee to create new, specific ICD-10 codes for FH in January 2014.

Last Updated: Monday, 19-Sep-2016 14:15:00 EDT

This year, Familial Hypercholesterolemia (FH) Awareness Day is on September 24, 2016. It was initiated by The FH Foundation as part of their mission to raise awareness of FH in the public.

The National Lipid Association and the Foundation are thankful once again for another successful year of meetings and fundraising. But we still have much work to do.

Article By:

ANNE C. GOLDBERG, MD, FNLA

President, Foundation of the National Lipid Association
Professor of Medicine
Washington University School of Medicine
St. Louis, MO

Diplomate, American Board of Clinical Lipidology

0
No votes yet

Some patients refuse statin therapy or cannot tolerate its side effects. Many of these patients seek alternative therapies, including red yeast rice (RYR), a widely available herbal supplement made by culturing a yeast, Monascus purpureus, on rice. This process produces 14 monacolins, compounds that inhibit HMG- CoA reductase, the rate-limiting step in hepatic cholesterol synthesis.1 One of the monacolins produced is monacolin K, which is chemically identical to lovastatin.

Article By:

RAM Y. GORDON, MD

Cardiac Specialists
Yale-New Haven Health System
Fairfield, CT

Diplomate, American Board of Clinical Lipidology

DAVID J. BECKER, MD

Division of Cardiology
Temple University Hospital
Philadelphia, PA

 

3.5
Average: 3.5 (2 votes)